European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Nal2/Rif9/Rtt, Live, Status: Authorised

Submitted by Anonymous (not verified) on 12 November 2026 - 16:05

Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Nal2/Rif9/Rtt, Live, Status: Authorised

EMA annual call with General Practitioner Organisations' representatives, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 13:00 (CET) to 20 November 2026, 15:00 (CET)

Submitted by Anonymous (not verified) on 12 November 2026 - 15:58

EMA annual call with General Practitioner Organisations' representatives, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 13:00 (CET) to 20 November 2026, 15:00 (CET)

Referral: Parenteral iron-containing medicinal products, ferric carboxymaltose,ferric derisomaltose,ferric gluconate,ferric hydroxide polymaltose complex,iron dextran,iron sucrose Article 31 referrals Procedure started, 12/11/2026

Submitted by Anonymous (not verified) on 12 November 2026 - 15:38

Referral: Parenteral iron-containing medicinal products, ferric carboxymaltose,ferric derisomaltose,ferric gluconate,ferric hydroxide polymaltose complex,iron dextran,iron sucrose Article 31 referrals Procedure started, 12/11/2026

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 12 November 2026 - 15:22

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised

Submitted by Anonymous (not verified) on 12 November 2026 - 15:18

Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness